Analysed ALPHA TAU MEDICAL LTD (DRTS:NASDAQ) News Sources
Alpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer Studies
27-04-2026
yahoo.com
Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026
04-05-2026
yahoo.com
Alpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer Combination with Pembrolizumab
05-05-2026
yahoo.com
Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute
07-05-2026
yahoo.com
Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma
08-05-2026
yahoo.com
Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma
08-05-2026
yahoo.com
Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Observed - Conference Call Scheduled for 8:30am ET
11-05-2026
yahoo.com
Alpha Tau Medical Shares Early REGAIN Data: 2 Complete Responses in Glioblastoma Study
11-05-2026
marketbeat.com
What is the current price of ALPHA TAU MEDICAL LTD (DRTS:NASDAQ)?
The current price of ALPHA TAU MEDICAL LTD (DRTS:NASDAQ) is $10.29.
ALPHA TAU MEDICAL LTD (DRTS:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALPHA TAU MEDICAL LTD (DRTS:NASDAQ) since the previous trading day is $-0.08.
ALPHA TAU MEDICAL LTD (DRTS:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALPHA TAU MEDICAL LTD (DRTS:NASDAQ) since the previous trading day is -0.7715%.
What is the most recent average sentiment score for ALPHA TAU MEDICAL LTD (DRTS:NASDAQ)?
The most recent average sentiment score for ALPHA TAU MEDICAL LTD (DRTS:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for ALPHA TAU MEDICAL LTD (DRTS:NASDAQ)?
The most recent sentiment for ALPHA TAU MEDICAL LTD (DRTS:NASDAQ) is .
SEC-8K** Filing Available For ALPHA TAU MEDICAL LTD (DRTS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.